Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Common Stock, par value $0.004 per share ("Shares")
-
Shares outstanding
-
22,866,677
-
Total 13F shares
-
31,374,408
-
Share change
-
-1,172,459
-
Total reported value
-
$567,252,558
-
Put/Call ratio
-
205%
-
Price per share
-
$18.08
-
Number of holders
-
98
-
Value change
-
-$28,664,876
-
Number of buys
-
49
-
Number of sells
-
52
Institutional Holders of BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) as of Q4 2023
As of 31 Dec 2023,
BICYCLE THERAPEUTICS PLC - Common Stock, par value $0.004 per share ("Shares") (BCYC) was held by
98 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,374,408 shares.
The largest 10 holders included
Paradigm Biocapital Advisors LP, Deep Track Capital, LP, Jefferies Financial Group Inc., BAKER BROS. ADVISORS LP, TYBOURNE CAPITAL MANAGEMENT (HK) LTD, First Light Asset Management, LLC, ARMISTICE CAPITAL, LLC, MORGAN STANLEY, Polar Capital Holdings Plc, and WESTFIELD CAPITAL MANAGEMENT CO LP.
This page lists
98
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.